PFC

warning: Creating default object from empty value in /home/hemporg/public_html/news/modules/taxonomy/taxonomy.pages.inc on line 34.

Maryland: Industry Training For Medical Cannabis Applicants Set For Oct. 12

MarylandMedicalMarijuana

Leading Cannabis Consumer Safety and Regulatory Compliance Experts Offer Networking and Education Opportunity

The Patient Focused Certification (PFC) program on October 12 will host a Maryland application preparation event for applicants seeking licenses to operate medical cannabis cultivation, processing or dispensary locations in Maryland. This event will consist of a networking reception followed by an educational workshop with industry experts on Maryland’s application process and best practices to meet regulatory requirements.

The Maryland Cannabis Commission began accepting applications on September 28. The commission will issue 15 licenses for cultivation, up to 92 for dispensaries, and an unlimited number for processors.

Maryland has adopted the American Herbal Product Association's (AHPA) Recommendations for Regulators, which require businesses to meet staff training requirements, and robust product safety protocols; undergo rigorous on-site compliance audits; implement lot and batch tracking; and adhere to all local and state regulatory requirements.

“PFC is hosting this event to prepare Maryland’s cannabis industry to meet regulatory requirements and strengthen the commitment of industry professionals to provide quality care and safe medicine to patients,” said PFC Director Kristin Nevedal.

U.S.: Best Practices Advocated For Labeling, Manufacturing Cannabis and Hemp Products

MedicalCannabisUnityConference2015.JPG

Groups convene in Washington, DC for third annual national medical cannabis conference March 27-31

The American Herbal Products Association (AHPA) Cannabis Committee, in coordination with Americans for Safe Access (ASA), and the Hemp Industries Association (HIA), has announced the release of a joint statement advocating for implementation of best practices for the regulation of consumable, topical, and inhalant cannabis and hemp-derived products to ensure quality and consumer safety.

These best practices were developed with the input of numerous industry experts and establish common language and defined terms for the transparent and accurate labeling of these products to support responsible commerce and informed use of the cannabis plant.

AHPA, ASA and HIA will be promoting these best practices at the 3rd Annual National Medical Cannabis Unity Conference being held March 27-31, in Washington, DC.

Recommendations for plant part identification

The AHPA Cannabis Committee has established a policy that lawfully-marketed products consisting of or including Cannabis spp. ingredients that are intended for oral ingestion, topical application, or inhalation be labeled to identify the part of the Cannabis plant from which the ingredient is derived (e.g., seed oil, flower extract, or extract of aerial parts). This policy does not apply to parts of the Cannabis plant provided to consumers in unprocessed and recognizable forms.

U.S.: New Medical Marijuana Guidelines Issued By National Herbal Medicine Industry Group

AmericanHerbalProductsAssociation(AHPA)logo

Botanical medicine standards released as Colorado medical marijuana business sees first product recall in U.S.

The American Herbal Products Association (AHPA) on Tuesday released its long-awaited medical marijuana manufacturing guidelines, completing its compendium of industry standards which include regulatory recommendations for cannabis from seed to sale. The AHPA manufacturing guidelines come as licensed Colorado business "At Home Baked" sees the country's first medical marijuana product recall.

A new nationwide program called Patient Focused Certification (PFC), a project of Americans for Safe Access (ASA), aims to bring greater standardization to the medical marijuana industry. The PFC program uses the recently completed AHPA guidelines in combination with standards set by American Herbal Pharmacopoeia (AHP) for the plant's identity, purity, quality and botanical properties. Together, these standards have the means to bring greater accountability to the industry and increased safety for patients, according to the group.

"Although medical marijuana is one of the safest medicines used today, it's important for patients to have industry standards that ensure the highest product quality and reliability," said ASA Executive Director Steph Sherer. "The AHPA guidelines issued today not only provide a blueprint for product recalls, like the one in Denver, but also establishes sound manufacturing procedures that will help avoid such recalls in the future."

U.S.: New Nationwide Certification Program Aims To Bring Quality Assurance To Medical Marijuana

ASAPatientFocusedCertificationPFC

Independent certification will benefit patients, healthcare providers, and regulators implementing medical marijuana laws

Patient advocacy group Americans for Safe Access (ASA) on Tuesday launched a new nationwide program that the group says will certify the quality and reliability of medical marijuana products sold at licensed businesses. Patient Focused Certification (PFC) is the only nonprofit, third-party certification for the medical marijuana industry based on new quality standards issued by the American Herbal Products Association (AHPA) and the American Herbal Pharmacopeia (AHP), according to ASA.

Earlier this year, AHPA issued a series of recommendations for state regulators, providing standards for the medical marijuana industry in the areas of manufacturing, packaging and labeling, dispensary operations, and laboratory practices. AHPA has since issued standards for commercial medical marijuana products, as well as the reliability and quality of related services. More recently, AHP released a cannabis monograph that set standards for the plant's identity, purity, quality, and botanical properties.

"In every city I visit across this country, patients say product safety and quality assurance are the issues they care about," said ASA Executive Director Steph Sherer. "As a patient advocacy organization, it was a natural fit for Americans for Safe Access to fill this much needed gap."

Syndicate content